ND_Solutions
ActiveSummary
ND_Solutions has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €516,482 and a net result of €105,047. Equity is growing by ~24.8% per year across the filed fiscal years. Its solvency ranks better than 85% of 216 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability83▲+8
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €40,000 at 30 days acceptable
Liquidity ample (current ratio 8.89 against 9.83 in 2024; short-term debt: 11.2% and cash: 17.2% of total assets), and 11.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 72
Relative position
BE, all sectors
reference
Scientific research and development (NACE 72)
about 30% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
88.8%
Return on assets
18.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
18 d late
2024
3 d early
2023
27 d late
2022
29 d late
2021
3 d late
2020
25 d late
2019
74 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 4 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€516,482▲ 11.9%
2024 · €461,435
Total assets
€581,913▲ 13.3%
2024 · €513,722
Net result
€105,047▲ 35.0%
2024 · €77,839
Working capital
€516,482▲ 11.9%
2024 · €461,435
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€212,621▲ 366%€147,642▼ 30.6%€120,152▼ 18.6%€102,632▼ 14.6%€127,206▲ 23.9%
Net result€144,938above the sector's middle half▲ 360%€100,632above the sector's middle half▼ 30.6%€84,087above the sector's middle half▼ 16.4%€77,839within the sector's middle half▼ 7.4%€105,047within the sector's middle half▲ 35.0%
Equity€238,877within the sector's middle half▲ 154%€339,509within the sector's middle half▲ 42.1%€423,596above the sector's middle half▲ 24.8%€461,435above the sector's middle half▲ 8.9%€516,482within the sector's middle half▲ 11.9%
Total assets€262,197within the sector's middle half▲ 139%€361,750within the sector's middle half▲ 38.0%€436,648within the sector's middle half▲ 20.7%€513,722within the sector's middle half▲ 17.7%€581,913within the sector's middle half▲ 13.3%
Debt€23,319▲ 48.8%€22,241▼ 4.6%€13,052▼ 41.3%€52,287▲ 301%€65,431▲ 25.1%
Working capital€238,877▲ 154%€339,509▲ 42.1%€423,596▲ 24.8%€461,435▲ 8.9%€516,482▲ 11.9%
Solvency91.1%above the sector's middle half▲ 5.4pp93.9%above the sector's middle half▲ 2.7pp97.0%above the sector's middle half▲ 3.2pp89.8%above the sector's middle half▼ 7.2pp88.8%above the sector's middle half▼ 1.1pp
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 24% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €581,913
Equity
€516,482 ▲ 11.9%
Debt
€65,431 ▲ 25.1%
Debt's share of the balance-sheet total rises from 10.2% to 11.2%. Equity and debt are higher.
Key figures and ratios
Current ratio
8.89▼
2024 · 9.83
Debt to equity
0.13▲
2024 · 0.11
ROE
20.3%▲
2024 · 16.9%
ROA
18.1%▲
2024 · 15.2%
Debt ≤ 1 year
€65,431▲
2024 · €52,287
Income taxes
€45,500▲
2024 · €30,815
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,776 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.5%
went bankrupt
2.6%
stopped otherwise
97%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,776 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Other operating charges640/8 | €55 | €57 | €64 | €311 | €66 | ▼ 78.8% |
| Gross operating margin9900 | €212,676 | €147,699 | €120,216 | €102,943 | €127,271 | ▲ 23.6% |
| Operating profit (loss)9901 | €212,621 | €147,642 | €120,152 | €102,632 | €127,206 | ▲ 23.9% |
| Financial income75/76B | - | €1,326 | €6,235 | €8,249 | €26,552 | ▲ 222% |
| Recurring financial income75 | - | €1,326 | €6,235 | €8,249 | €26,552 | ▲ 222% |
| Financial charges65/66B | €45 | €1,291 | €2,648 | €2,227 | €3,211 | ▲ 44.2% |
| Recurring financial charges65 | €45 | €1,291 | €2,648 | €2,227 | €3,211 | ▲ 44.2% |
| Profit (loss) for the period before taxes9903 | €212,576 | €147,677 | €123,739 | €108,654 | €150,547 | ▲ 38.6% |
| Income taxes67/77 | €67,638 | €47,045 | €39,652 | €30,815 | €45,500 | ▲ 47.7% |
| Profit (loss) for the period9904 | €144,938 | €100,632 | €84,087 | €77,839 | €105,047 | ▲ 35.0% |
| Profit (loss) for the period to be appropriated9905 | €144,938 | €100,632 | €84,087 | €77,839 | €105,047 | ▲ 35.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €262,197 | €361,750 | €436,648 | €513,722 | €581,913 | ▲ 13.3% |
| Current assets29/58 | €262,197 | €361,750 | €436,648 | €513,722 | €581,913 | ▲ 13.3% |
| Amounts receivable within one year40/41 | €6,465 | €18,084 | €29,331 | €16,642 | €11,072 | ▼ 33.5% |
| Trade receivables40 | - | €13,129 | €28,913 | €6,207 | €11,072 | ▲ 78.4% |
| Other amounts receivable41 | €6,465 | €4,955 | €418 | €10,435 | - | - |
| Current investments50/53 | - | €198,184 | €322,390 | €414,089 | €470,652 | ▲ 13.7% |
| Cash at bank and in hand54/58 | €255,732 | €145,482 | €84,928 | €79,991 | €100,190 | ▲ 25.3% |
| Deferred charges and accrued income490/1 | - | - | - | €3,000 | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €262,197 | €361,750 | €436,648 | €513,722 | €581,913 | ▲ 13.3% |
| Equity10/15 | €238,877 | €339,509 | €423,596 | €461,435 | €516,482 | ▲ 11.9% |
| Contributions10/11 | €20,000 | €20,000 | €20,000 | €20,000 | €20,000 | = |
| Capital10 | €20,000 | €20,000 | - | - | - | - |
| Issued capital100 | €20,000 | €20,000 | - | - | - | - |
| Outside capital11 | - | - | €20,000 | €20,000 | €20,000 | = |
| Other1109/19 | - | - | €20,000 | €20,000 | €20,000 | = |
| Reserves13 | €218,877 | €319,509 | €403,596 | €441,435 | €496,435 | ▲ 12.5% |
| Distributable reserves133 | €218,877 | €319,509 | €403,596 | €441,435 | €496,435 | ▲ 12.5% |
| Profit (loss) carried forward14 | - | - | - | - | €47 | - |
| Amounts payable17/49 | €23,319 | €22,241 | €13,052 | €52,287 | €65,431 | ▲ 25.1% |
| Amounts payable within one year42/48 | €23,319 | €22,241 | €13,052 | €52,287 | €65,431 | ▲ 25.1% |
| Trade debts44 | - | - | €529 | - | - | - |
| Suppliers440/4 | - | - | €529 | - | - | - |
| Taxes, remuneration and social security45 | €21,861 | €20,782 | €11,065 | €18,287 | €22,931 | ▲ 25.4% |
| Taxes450/3 | €21,861 | €20,782 | €11,065 | €18,287 | €22,931 | ▲ 25.4% |
| Other amounts payable47/48 | €1,458 | €1,458 | €1,458 | €34,000 | €42,500 | ▲ 25.0% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €144,938 | €100,632 | €84,087 | €77,839 | €105,047 | ▲ 35.0% |
| Operating cash flow (approximation) | €144,938 | €100,632 | €84,087 | €77,839 | €105,047 | ▲ 35.0% |
| Change in cash | - | -€110,250 | -€60,554 | -€4,937 | €20,199 | ▲ 509% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 18 days late
2025
31-12
Financial
Equity above €500,000Eq €516,482 ▲11.9%
7 profitable years in a row build equity to €516,482.
28-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 27 days late
2023
31-12
Financial
Liquidity doublescurrent ratio 33.45
Current ratio from 16.27 to 33.45; short-term debt falls from €22,241 to €13,052.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
03-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 3 days late
2021
31-12
Financial
Highest result since 2019net €144,938 ▲360%
Operating result €212,621, net result €144,938, both a record.
31-12
Financial
Equity above €200,000Eq €238,877 ▲154%
3 profitable years in a row build equity to €238,877.
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 25 days late
2020
31-12
Financial
Weakest financial yearnet €31,496 ▼33.2%
Net result drops to €31,496, the lowest in the series; recovery starts the following year.
18-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grimbergen · 1 establishment unit since 2019
Ground area
737 m²
Building footprint
150 m²
Volume, LiDAR
942 m³
Parcel 23403H0078/00V004, Flanders · tallest building 8.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ND_Solutions
since 20192.287.795.874
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23403H0078/00V004 | Flanders | 737 m² | 1 · 150 m² | 8.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500DC4EO1BE861282
Similar companies · same sector, comparable size
NOVICREO
BE 0885.428.866
Fernelmont · Eq €519,259
Immunochem
BE 0896.472.416
Chaumont-Gistoux · Eq €513,103
IMEC International
BE 0817.807.097
Leuven · Eq €512,723
RAIN
BE 0750.660.927
Ukkel · Eq €510,557
REVISION IMPLANT
BE 0740.519.675
Oud-Heverlee · Eq €510,557
Of 1,177 companies in sector 72109 we hold annual accounts for 714. 482 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-03-2019
Fiscal year end31-12
Activities, NACEBEL 2025
72109Other research and development on natural sciences
71113Urban planning and landscape architecture
E-invoicing
Reachable via Peppol
Peppol ID
0208:0723732143
Registered
22-01-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.